QNTM
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
QNTM
13 hedge funds and large institutions have $549K invested in Quantum Biopharma Class B Subordinate Voting Shares in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more ownership
Funds ownership: 0.02% → 0.02% (+0%)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Holders
13
Holding in Top 10
–
Calls
$59K
Puts
$1K
Top Buyers
| 1 | +$22.2K | |
| 2 | +$20.7K | |
| 3 | +$13K | |
| 4 |
HF
HRT Financial
New York
|
+$13K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$7.79K |
Top Sellers
| 1 | -$41.1K | |
| 2 | -$16.5K | |
| 3 | -$11.7K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.36K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1 |